Merriman Curhan Ford Starts Polypore (PPO) at Buy
More News related to PPO
- Unusual 11 Mid-Day Movers 12/03: OGXI, PPO, BZH, GW Higher; IFX, HSNI, FCX, PALM Lower
- Polypore Int'l (PPO) CEO Buys 35K Shares
- Celgard Receives Battery Development Contract from USABC
- Polypore to Present At Robert W. Baird Industrial Conference
- Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: MET, BGS, PLAB, APA, HIW, PPO
More News related to New Coverage
- Raymond James Starts Millicom (MICC) at Strong Buy
- Stifel Nicolaus Starts City National (CYN) at Hold
- Stifel Nicolaus Starts eHealth (Nasdaq: HLTH) with a Buy
- Wasserman & Associates initiates coverage on American Physicians Service Group (AMPH) with a Buy
- Jesup & Lamont Initiates Coverage on AutoZone (AZO) with a Hold.
Merriman Curhan Ford initiates coverage on Polypore (NYSE: PPO) with a Buy rating.
Polypore International, Inc., a technology filtration company, engages in the development, manufacture, and marketing of specialized microporous membranes used in separation and filtration processes.
Related Categories
New CoverageStocks Mentioned
+1.42Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
